MNPRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Monopar Therapeutics
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$71.47+2.20 (+3.18%)
Close on Oct 19, 2026
- Market cap
- $610.53M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Monopar Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Aug 12, 2026 | Aug 12, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 12, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 22, 2026 | Jul 22, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 30, 2026 | Jun 30, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 26, 2026 | Jun 26, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 22, 2026 | Jun 23, 2026 | SEC EDGAR |
| Current report | 8-K | May 29, 2026 | May 29, 2026 | SEC EDGAR |
| Current report | 8-K | May 19, 2026 | May 19, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 14, 2026 | SEC EDGAR |
| Current report | 8-K | May 14, 2026 | May 14, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 22, 2026 | Apr 30, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 19, 2026 | Apr 20, 2026 | SEC EDGAR |
| Annual report, amended | 10-K/A | Dec 31, 2025 | Apr 1, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 27, 2026 | Mar 27, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 27, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 2, 2026 | Mar 2, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 13, 2025 | Nov 13, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 13, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 9, 2025 | Nov 10, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 23, 2025 | Sep 24, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 15, 2025 | Sep 15, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2025 | Aug 12, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 12, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 17, 2025 | Jun 23, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 13, 2025 | SEC EDGAR |
| Current report | 8-K | May 13, 2025 | May 13, 2025 | SEC EDGAR |
| Current report | 8-K | May 7, 2025 | May 7, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 17, 2025 | Apr 30, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 31, 2025 | Mar 31, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 31, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 27, 2025 | Mar 3, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 19, 2025 | Feb 24, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 20, 2024 | Dec 23, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 6, 2024 | Dec 6, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 8, 2024 | Nov 8, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 8, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 28, 2024 | Oct 30, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 23, 2024 | Oct 24, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 22, 2024 | Oct 22, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 15, 2024 | Oct 15, 2024 | SEC EDGAR |